Hyperglycemia increased brain ischemia injury through extracellular signal-regulated protein Kinase

Jian-Zhong Zhang1, Li Jing, Ai-Ling Ma

  • 1Institute of Immunopathology, School of Life Science & Technology, Xi'an Jiaotong University, Xi'an 710061, China. zhangjz@nxmc.edu.cn

Insights

Hyperglycemia worsens brain damage after stroke by increasing extracellular signal-regulated kinase (ERK) phosphorylation. Inhibiting ERK reduces this damage, suggesting ERK

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathophysiology

Background:

  • Transient brain ischemia, a common stroke complication, can be exacerbated by hyperglycemia.
  • Mitogen-activated protein kinases (MAPKs), including Extracellular signal-regulated kinase (ERK), are implicated in cellular stress responses.

Purpose of the Study:

  • To investigate the role of ERK phosphorylation in transient brain ischemia under hyperglycemic conditions.
  • To elucidate the molecular mechanisms by which hyperglycemia worsens stroke-related brain damage.

Main Methods:

  • Global brain ischemia was induced in rats under normoglycemic (CIN) and hyperglycemic (CIH) conditions.
  • ERK phosphorylation was assessed using immunohistochemistry and Western blot analysis.
  • The effect of an ERK inhibitor (U0126) on neuronal survival was evaluated in hyperglycemic ischemic rats.

Main Results:

  • Increased phospho-ERK1/2 immunoreactive neurons were observed in the cingulate cortex and hippocampus after ischemia/reperfusion in both CIN and CIH groups.
  • Hyperglycemia (CIH) led to a significant increase in phospho-ERK1/2-positive neurons compared to normoglycemic conditions (CIN).
  • U0126 treatment significantly reduced phospho-ERK1/2 levels and immunoreactive cells in CIH rats, indicating ERK pathway involvement.

Conclusions:

  • ERK1/2 phosphorylation is upregulated during transient brain ischemia and significantly enhanced under hyperglycemic conditions.
  • Hyperglycemia exacerbates ischemic brain injury, at least partly, through increased ERK1/2 activation.
  • Targeting the ERK pathway may offer a therapeutic strategy to mitigate brain damage in stroke patients with hyperglycemia.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...